Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stem cell therapy for Parkinson’s disease: safety and modeling

16 Sept 2019

Abstract excerpt

For decades, clinicians have developed medications and therapies to alleviate the symptoms of Parkinson's disease, but no treatment currently can slow or even stop the progression of this localized neurodegeneration. Fortunately, sparked by the genetic revolution, stem cell reprogramming research and the advancing capabilities of personalization in medicine enable forward-thinking to unprecedented...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31535640
DOI: 10.4103/1673-5374.264446

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stem cell therapy for Parkinson’s disease: safety and modelingPMID 31535640Read ↗

Induced pluripotent stem cells and Parkinson's disease: modelling and treatmentSemantic proximity Read ↗

Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease ModelingSemantic proximity Read ↗

Advancing Parkinson’s disease treatment: cell replacement therapy with neurons derived from pluripotent stem cellsSemantic proximity Read ↗

Towards stem cell based therapies for Parkinson's diseaseSemantic proximity Read ↗

Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem CellsSemantic proximity Read ↗

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challengesSemantic proximity Read ↗

Stem cell therapies for Parkinson’s diseaseSemantic proximity Read ↗

Parkinson's Disease and Mesenchymal Stem Cells: Potential for Cell-Based TherapySemantic proximity Read ↗

Autologous Versus Allogeneic iPSC-Derived Dopaminergic Neuron Therapy for Parkinson’s Disease: Molecular Mechanisms and Translational Trade-OffsSemantic proximity Read ↗

Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discoverySemantic proximity Read ↗

Cell reprogramming therapy for Parkinson’s diseaseSemantic proximity Read ↗

Modeling Parkinson’s Disease Using Induced Pluripotent Stem CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.